Azithromycin for Child Survival in Niger II — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Azithromycin for Child Survival in Niger II — Stella

Home/Mortality/

View on ClinicalTrials.gov

Recruiting

Back to Mortality trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Niger

Program National de Santé Oculaire, Niamey

Key details

Phase

Post-approval study

Sponsor

University of California, San Francisco

Collaborators

Centre de recherche et interventions en santé publique (CRISP), Ministère de la Santé Publique du Niger

Enrollment target

~3,300,000 participants

Started

April 2024

Primary completion

April 2028

Age range

1 Month – 59 Months

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.